Biophar Lifesciences

What Biophar Lifesciences does

Biophar Lifesciences Pvt. Ltd. is an Indian pharmaceutical company headquartered in Zirakpur (Chandigarh region) with WHO-GMP certified manufacturing facilities in the Baddi pharma hub, Himachal Pradesh. Founded in 2004 and operating with 51-100 employees under Director Gulshan Rawat, the company manufactures and supplies a portfolio of 2,500+ pharmaceutical products spanning 15 therapeutic segments including cardiology, neurology, dermatology, gastroenterology, diabetic care, ophthalmology, and nutraceuticals, offered as tablets, capsules, syrups, injectables, ointments, and creams.

The company's go-to-market is built around three revenue streams: (1) a PCD (Propaganda Cum Distribution) Pharma Franchise model that grants exclusive monopoly rights to distributor partners in assigned territories across 31 Indian regions, supported by tiered franchise investment packages ranging from INR 25,000 to over INR 3,00,000; (2) third-party contract manufacturing services for pharma companies and healthcare marketers, executed through partners including Akums Drugs & Pharmaceuticals, Hetero Labs, Purple INC, Frammeds, and Windlas Biotech; and (3) direct pharmaceutical product sales to doctors, hospitals, and pharmacies.

Biophar holds WHO-GMP, ISO, and DCGI regulatory approvals and provides franchise partners with bundled marketing support — visual aids, MR bags, brochures, and digital assistance — to drive product uptake at the territory level. The company is privately held with no external institutional funding, operates on a bootstrapped basis, and discloses no revenue figures. Recent activity through 2026 has centered on new product launches across ophthalmology, gastroenterology, cardiovascular, and digestive health segments.

Name

Biophar Lifesciences

Legal name

Biophar Lifesciences Pvt. Ltd.

Website

https://biophargroup.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Chandigarh

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. PCD Pharma Franchise: Revenue generated from franchise partners who pay for exclusive monopoly rights, marketing support, and access to 2500+ pharmaceutical products for distribution in their territories
2. Third-Party Manufacturing: Contract manufacturing services for pharmaceutical companies, healthcare marketers, and distributors who outsource production to Biophar's WHO-GMP certified facilities
3. Pharmaceutical Product Sales: Direct sales of pharmaceutical products including tablets, capsules, syrups, injectables, ointments, and nutraceuticals across various therapeutic segments

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Biophar Lifesciences manufactures, markets, exports, and supplies pharmaceutical formulations including tablets, softgel capsules, syrups, injectables, and nutraceuticals. The company operates WHO-GMP certified production facilities in Baddi, India and offers PCD Pharma Franchise and third-party manufacturing services to distributors and pharmaceutical companies across India.

Product overview

Biophar Lifesciences is a pharmaceutical company offering a diverse portfolio of over 2,500 pharmaceutical products through PCD Pharma Franchise and third-party manufacturing services. The company operates as a pharma franchise/network marketing organization with WHO-GMP certified manufacturing facilities in the Baddi pharma hub. Their product portfolio includes tablets, capsules, syrups, injectables, ointments, creams, and nutraceuticals across 15 specialty therapeutic ranges: Ortho & Surgery, Cardiac, Gastro, ENT, Gynae, Diabetic, Neuro & Psychiatry, Derma, General Physician, Ayurvedic, Dental, Critical Care, Ophthalmic, Pediatric, and Urology. Key products include Keptact Gel (Progesterone 8%), Vonoref-20 (Vonoprazan), Rabifer IT (Rabeprazole + Itopride), Dapawalk M (Dapagliflozin + Metformin), Vapvir (Valacyclovir), Calrado-Forte, and various antibiotic, nutritional, and supplements formulations. The company provides marketing support, monopoly rights, and distribution services to franchise partners.

Differentiator

Problem solved

Functional benefit

Products and services

• PCD Pharma Franchise

Quantifiable outcome

• 2500+ high-quality products available through franchise network
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core and minor.

• Akums Drugs & Pharmaceuticals LtdcoreStrategic or Co-development PartnerContract manufacturing partner producing pharmaceutical formulations for Biophar's product portfolio. Akums is one of India's largest contract manufacturers with WHO-GMP certified facilities.
• Hetero Labs LimitedcoreStrategic or Co-development PartnerManufacturing partner for products like Vonoref-20 (Vonoprazan 20mg). Hetero is a globally recognized pharmaceutical company manufacturing APIs and formulations.
• Purple INCminorStrategic or Co-development PartnerContract manufacturing partner for pharmaceutical products included in Biophar's product portfolio.
• FrammedsminorStrategic or Co-development PartnerContract manufacturing partner for pharmaceutical formulations.
• Windlas BiotechminorStrategic or Co-development PartnerContract manufacturing partner for pharmaceutical products.

Scale indicators3 records

Expansion highlights5 records

Direct peers

• Akums Drugs & Pharmaceuticals: One of India's largest contract manufacturers offering third-party manufacturing and PCD franchise services across a wide therapeutic portfolio. Highly comparable to Biophar in third-party manufacturing and franchise distribution model; Akums is also an existing Biophar partner.
• Centaur Pharmaceuticals: Indian pharma company operating PCD franchise and contract manufacturing models with WHO-GMP facilities. Closely comparable in business model (PCD franchise + third-party manufacturing) and target market (Indian distributors and pharma entrepreneurs).
• Consern Pharma: PCD pharma franchise company offering generic formulations across multiple therapeutic segments with exclusive monopoly franchise rights. Directly comparable franchise model, product breadth approach, and SMB distributor target customer.

Broad incumbents

• Mankind Pharma: One of India's largest domestic pharma companies with extensive generic portfolio and growing OTC presence. Overlaps with Biophar's generic manufacturing and franchise distribution; serves as a benchmark for what scaled Indian generic-pharma PCD operations can become.
• Cipla: Large Indian multinational pharmaceutical company with broad generic portfolio across respiratory, cardiology, and other segments. Comparable in finished pharmaceutical manufacturing; represents the scaled incumbent Biophar competes with in generic segments.
• Alkem Laboratories: Leading Indian pharma manufacturer with strong presence in acute and chronic generics across multiple therapeutic categories. Overlaps with Biophar's portfolio in anti-infectives, gastro, and chronic disease formulations.
• Sun Pharmaceutical Industries: India's largest pharma company by revenue with extensive generics, specialty, and API portfolio. Comparable in finished pharmaceutical manufacturing and broad therapeutic coverage; represents large-incumbent competitive pressure on PCD franchise pricing.
• Intas Pharmaceuticals: Large Indian pharma company with strong generics, biosimilars, and contract manufacturing operations. Comparable in finished dosage manufacturing and third-party services; competes in several therapeutic segments where Biophar operates.
• Zydus Lifesciences: Integrated Indian pharma company with generics, biosimilars, and consumer health operations. Comparable in finished pharmaceutical manufacturing; competes across multiple therapeutic categories Biophar covers.
• Torrent Pharmaceuticals: Indian pharma company focused on generics, specialty, and chronic disease segments including cardiology and CNS. Overlaps with Biophar in cardiac, neuro, and chronic therapeutic categories as a broader incumbent competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• Xx.com/Biophar_Life
• Facebookfacebook.com/BiopharGroup

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biophar Lifesciences